News

CoverGirl spokeswoman Queen Latifah reigns as Pantene’s newest brand ambassador

BY Antoinette Alexander

CINCINNATI — Current CoverGirl spokeswoman Queen Latifah is now the new face of Pantene and will support the Truly Relaxed and Truly Natural collections, Procter & Gamble has announced.

“Queen Latifah not only exudes inner and outer beauty, but she is a brilliant business woman who shines in every aspect of her work,” stated Kevin Crociata, marketing director of North American hair care at P&G. “We believe her strong, playful personality and passion for life resonates with women. Her honest and approachable attitude makes her a perfect addition to the Pantene family. Women really listen to her, her opinion matters.”

Latifah will appear in the brand’s marketing campaign, including TV and print advertising, in-store displays, digital, social media and public relations campaigns, beginning in September.

Known for her talents as an actress, producer, rapper and comedian, she also has her own cosmetic line with CoverGirl, the Queen Collection, and is set to debut her new talk show, “The Queen Latifah Show,” in September.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Otsuka to buy Astex for $886 million

BY Alaric DeArment

TOKYO — Japanese drug maker Otsuka Pharmaceutical Co. is buying U.S.-based Astex Pharmaceuticals for $886 million, Otsuka said Thursday.

Astex, based in Dublin, Calif., uses a drug-discovery system known as fragment-based drug discovery, which enables rapid discovery and development of compounds for target proteins implicated in diseases and works by evaluating binding of target proteins with small molecules through 3D structural analysis. Astex developed and launched the chemotherapy drug Dacogen (decitabine), currently sold by Eisai.

"I hope that this acquisition of Astex will strengthen not only our cancer portfolio, but also our drug-discovery research in the central nervous system field, through the acquisition of Astex’s fragment-based drug design technology," Otsuka president and representative director Taro Iwamoto said. "Astex’s unique fragment-based drug discovery technology and clinical oncology research and development capabilities, born out of the passion of its researchers, exemplify our corporate mottos and believe in ‘sozosei’ (creativity) and ‘jissho’ (proof through execution)."


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

FY2013 sales grow by 6% at Costco

BY Alaric DeArment

ISSAQUAH, Wash. – Costco reported sales of $102.9 billion for fiscal year 2013, the club retailer said Thursday.

The figure for the fiscal year, which ended Sunday, represented a 6% increase over fiscal year 2012’s $97.1 billion. For the fourth quarter, the company reported sales of $31.8 billion, a 1% increase over fourth-quarter 2012’s $31.5 billion.

Sales for the month of August were $7.95 billion, a 7% increase over August 2012’s $7.44 billion.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?